These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Mechanisms of sudden cardiac death. Brugada P; Andries EW; Mont L; Gursoy S; Willems H; Kaissar S Drugs; 1991; 41 Suppl 2():16-23. PubMed ID: 1711966 [TBL] [Abstract][Full Text] [Related]
4. Methodology for clinical trials with antiarrhythmic drugs to prevent cardiac death: US experience. Bigger JT Cardiology; 1987; 74 Suppl 2():40-56. PubMed ID: 3621278 [TBL] [Abstract][Full Text] [Related]
5. Prognosis of ventricular arrhythmias in relation to sudden cardiac death: therapeutic implications. Surawicz B J Am Coll Cardiol; 1987 Aug; 10(2):435-47. PubMed ID: 3298363 [TBL] [Abstract][Full Text] [Related]
6. Role of invasive electrophysiological testing in the evaluation and treatment of patients at high risk for sudden cardiac death. Ruskin JN Circulation; 1992 Jan; 85(1 Suppl):I152-9. PubMed ID: 1728498 [TBL] [Abstract][Full Text] [Related]
7. [Detection of patients at risk for sudden heart death by long-term ECG. The role of life-threatening ventricular arrhythmias]. Hombach V; Höpp HW; Osterspey A; Winter U; Deutsch H; Hilger HH Herz; 1984 Feb; 9(1):6-25. PubMed ID: 6200415 [TBL] [Abstract][Full Text] [Related]
8. [Cardiac sudden death in the aged]. Ohkawa S Kokyu To Junkan; 1989 Mar; 37(3):257-62. PubMed ID: 2734503 [No Abstract] [Full Text] [Related]
9. [Factors in sudden and non-sudden death after myocardial infarction]. Lascault G; Fillette F; Grosgogeat Y Presse Med; 1987 Sep; 16(31):1533-7. PubMed ID: 2889204 [TBL] [Abstract][Full Text] [Related]
10. [Late potentials, myocardial kinetics and ventricular vulnerability as markers of sudden death after myocardial infarct]. D'Aulerio M; Gronda M; Prando MD; Occhetta E; Makmur J; Rossi L; Rossi P G Ital Cardiol; 1986 Feb; 16(2):114-26. PubMed ID: 3721103 [TBL] [Abstract][Full Text] [Related]
11. Risk stratification of patients with complex ventricular arrhythmias. Value of ambulatory electrocardiographic recording, programmed electrical stimulation and the signal-averaged electrocardiogram. el-Sherif N; Turitto G; Fontaine JM Herz; 1988 Jun; 13(3):204-14. PubMed ID: 2456972 [TBL] [Abstract][Full Text] [Related]
12. When is drug therapy warranted to prevent sudden cardiac death? Singh BN Drugs; 1991; 41 Suppl 2():24-46. PubMed ID: 1711967 [TBL] [Abstract][Full Text] [Related]
13. Sudden cardiac death--an approach to management of the patient at risk. Podrid PJ; Blatt CM Herz; 1984 Apr; 9(2):65-76. PubMed ID: 6714916 [TBL] [Abstract][Full Text] [Related]
14. [The predictive value for major arrhythmic events of ventricular arrhythmias, particularly nonsustained ventricular tachycardias, in the subacute phase of a fibrinolyzed infarct. An analysis of GISSI-2 data. Gruppo Italiano per lo Studio della Streptochinasi nell'Infarto Miocardico]. Giani P; Avanzini F; Bagliani G; Galati A; Pucci P; Santoro E G Ital Cardiol; 1995 Jan; 25(1):77-87. PubMed ID: 7642014 [TBL] [Abstract][Full Text] [Related]